Uni-Bio Science Group Limited (HKG:0690)
0.0760
-0.0040 (-5.00%)
Jul 31, 2026, 4:08 PM HKT
Uni-Bio Science Group Market Cap
Uni-Bio Science Group has a market cap or net worth of 453.81 million as of July 31, 2026. Its market cap has decreased by -44.53% in one year.
Market Cap
453.81M
Enterprise Value
358.03M
Revenue
586.21M
Ranking
n/a
PE Ratio
4.87
Stock Price
0.08
ChartMarket Cap Chart
Since November 12, 2001, Uni-Bio Science Group's market cap has increased from 1.02M to 453.81M, an increase of 44,392.25%. That is a compound annual growth rate of 27.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 453.81M | -33.91% |
| Dec 31, 2025 | 686.69M | 91.67% |
| Dec 31, 2024 | 358.27M | -20.75% |
| Dec 29, 2023 | 452.07M | -1.35% |
| Dec 30, 2022 | 458.26M | -14.08% |
| Dec 31, 2021 | 533.38M | -27.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sunho Biologics | 970.43M |
| Cutia Therapeutics | 875.72M |
| Kintor Pharmaceutical | 809.85M |
| Wuhan YZY Biopharma | 715.30M |
| Brii Biosciences | 692.93M |
| JW (Cayman) Therapeutics Co. | 621.02M |
| Shanghai Bio-heart Biological Technology | 557.43M |
| 3D Medicines | 545.94M |